These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35960189)

  • 1. Neural network on interval-censored data with application to the prediction of Alzheimer's disease.
    Sun T; Ding Y
    Biometrics; 2023 Sep; 79(3):2677-2690. PubMed ID: 35960189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
    Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
    Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rethinking modeling Alzheimer's disease progression from a multi-task learning perspective with deep recurrent neural network.
    Liang W; Zhang K; Cao P; Liu X; Yang J; Zaiane O
    Comput Biol Med; 2021 Nov; 138():104935. PubMed ID: 34656869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks.
    Abdelaziz M; Wang T; Elazab A
    J Biomed Inform; 2021 Sep; 121():103863. PubMed ID: 34229061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression.
    Polhamus DG; Dolton MJ; Rogers JA; Honigberg L; Jin JY; Quartino A
    J Prev Alzheimers Dis; 2023; 10(2):212-222. PubMed ID: 36946448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Landscape of Late-Phase Clinical Trials for Alzheimer's Disease: Comparing Regional Variation Between Subjects in Japan and North America.
    Kikuchi M; Adachi N; Matsumaru N; Tsukamoto K
    Pharmaceut Med; 2019 Dec; 33(6):511-518. PubMed ID: 31933241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Alzheimer's disease progression using deep recurrent neural networks.
    Nguyen M; He T; An L; Alexander DC; Feng J; Yeo BTT;
    Neuroimage; 2020 Nov; 222():117203. PubMed ID: 32763427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo Ensemble Neural Network for the diagnosis of Alzheimer's disease.
    Liu C; Huang F; Qiu A;
    Neural Netw; 2023 Feb; 159():14-24. PubMed ID: 36525914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep causal feature extraction and inference with neuroimaging genetic data.
    Yao Y; Charkraborty D; Zhang L; Shen X; ; Pan W
    Stat Med; 2023 Sep; 42(20):3665-3684. PubMed ID: 37336556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hybrid Convolutional and Recurrent Neural Network for Hippocampus Analysis in Alzheimer's Disease.
    Li F; Liu M;
    J Neurosci Methods; 2019 Jul; 323():108-118. PubMed ID: 31132373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing forgetfulness: can episodic-memory tests predict early Alzheimer's disease?
    Warren SL; Moustafa AA; Alashwal H;
    Exp Brain Res; 2021 Sep; 239(9):2925-2937. PubMed ID: 34313791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian inference and dynamic prediction of multivariate joint model with functional data: An application to Alzheimer's disease.
    Zou H; Li K; Zeng D; Luo S;
    Stat Med; 2021 Dec; 40(30):6855-6872. PubMed ID: 34649301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copula-based semiparametric regression method for bivariate data under general interval censoring.
    Sun T; Ding Y
    Biostatistics; 2021 Apr; 22(2):315-330. PubMed ID: 31506682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's Disease.
    Daunt P; Ballard CG; Creese B; Davidson G; Hardy J; Oshota O; Pither RJ; Gibson AM
    J Prev Alzheimers Dis; 2021; 8(1):78-83. PubMed ID: 33336228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Deep Learning Approach for Automated Diagnosis and Multi-Class Classification of Alzheimer's Disease Stages Using Resting-State fMRI and Residual Neural Networks.
    Ramzan F; Khan MUG; Rehmat A; Iqbal S; Saba T; Rehman A; Mehmood Z
    J Med Syst; 2019 Dec; 44(2):37. PubMed ID: 31853655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.